- Rob Moore, principal clinical scientist,
- Rebecca Wood, clinical scientist
- Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton and Hove, UK
- robert.moore8{at}nhs.net
We agree with the concerns raised by Eastwood and Schlossenberg about the changing drug landscape in the UK.1 There is a need in healthcare for a functional surveillance system to identify emerging threats.
Regrettably, the availability of analytical toxicology services in the NHS is exceptionally disparate. Apart from a few very specialist laboratories, a significant amount of …